T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers Meeting Abstract
| Authors: | Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S. |
| Abstract Title: | T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers |
| Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 7 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 6-10 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2019-11-01 |
| Start Page: | 282 |
| Language: | English |
| ACCESSION: | WOS:000496473200595 |
| PROVIDER: | wos |
| PMCID: | PMC6833189 |
| PUBMED: | 31694725 |
| DOI: | 10.1186/s40425-019-0763-1 |
| Notes: | Meeting Abstract: P171 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
